Beyond impairing DNA repair, DNA-PKcs inhibitors have been shown to modulate the TME under ionizing radiation, suppressing VEGF and HIF-1α expression in glioma cells and impeding microvascular endothelial cell proliferation and metastasis—a finding that opens new avenues for TME-targeted therapies [163]. The gene discussed is PRKDC; the disease is central nervous system cancer.